These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4312115)

  • 1. Specific retention of an inhibitor of 3-beta-hydroxysteroid dehydrogenase in enzyme-containing tissues of the rat.
    Goldman AS
    Endocrinology; 1970 Mar; 86(3):678-86. PubMed ID: 4312115
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ACTH on enzymatic defect produced in vivo by a competitive inhibitor of 3-beta-hydroxysteroid dehydrogenase.
    Goldman AS
    Endocrinology; 1970 Mar; 86(3):583-9. PubMed ID: 4312112
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of label in rat offspring after maternal administration of a 14C-labeled inhibitor of 3beta-hydroxysteroid dehydrogenase.
    Goldman AS; Kenneck CZ
    Endocrinology; 1970 Apr; 86(4):711-6. PubMed ID: 4312977
    [No Abstract]   [Full Text] [Related]  

  • 4. Maternal and fetal effects of two inhibitors of 3 beta-hydroxysteroid dehydrogenase and delta 5-4,3-ketosteroid isomerase in the rat.
    Goldman AS
    Endocrinology; 1969 Aug; 85(2):325-9. PubMed ID: 5784921
    [No Abstract]   [Full Text] [Related]  

  • 5. Competitive inhibition of adrenal delta 5-3 beta-hydroxysteroid dehydrogenase and delta 5-3-ketosteroid isomerase activities by adenosine 3',5'-monophosphate.
    McCune RW; Roberts S; Young PL
    J Biol Chem; 1970 Aug; 245(15):3859-67. PubMed ID: 4321768
    [No Abstract]   [Full Text] [Related]  

  • 6. The delta-5-3-beta-hydroxysteroid dehydrogenase of rat ovarian tissue. The effect of adenosine 3',5'-cyclic-monophosphoric acid.
    Sulimovici S; Boyd GS
    Eur J Biochem; 1969 Feb; 7(4):549-58. PubMed ID: 4388369
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies of steoidal inhibitors of delpha5, 3beta-hydroxysteroid dehydrogenase and delta5-delta4, 3-ketosteroid isomerase in Pseudomonas testosteroni and in bovine adrenals.
    Goldman AS
    J Clin Endocrinol Metab; 1968 Nov; 28(11):1539-46. PubMed ID: 5697036
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of 14 C-isoxazole in adrenals, ovaries, and breast carcinoma.
    Ryo UY; Beierwaltes WH
    J Nucl Med; 1973 Jun; 14(6):321-5. PubMed ID: 4349716
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of uptake with estradiol treatment of a radiolabeled irreversible competitive enzyme inhibitor in the adrenal cortices and ovaries of rats with endocrine "autonomous" breast carcinomas.
    Ryo UY; Beierwaltes WH; Ice RD
    J Nucl Med; 1974 Mar; 15(3):187-9. PubMed ID: 4813226
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of corticosterone formation and 3 -hydroxysteroid dehydrogenase activity in cell-free preparations of rat adrenals.
    Berger GM; Jones JD
    Endocrinology; 1971 Sep; 89(3):722-9. PubMed ID: 4398027
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitors of human adrenal C17-20 lyase and C19-5-ene, 3beta-hydroxysteroid dehydrogenase.
    Yates J; Deshpande N; Goldman AS
    J Steroid Biochem; 1975 Sep; 6(9):1325-7. PubMed ID: 1181487
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of Mammary gland defects in experimental congenital adrenal hyperplasia due to inhibition to 3 beta-hydroxysteroid dehydrogenase in rats.
    Neumann F; Goldman AS
    Endocrinology; 1970 May; 86(5):1169-71. PubMed ID: 4314068
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of congenital adrenocortical hyperplasia in rats by estradiol-17-beta and inhibition of 3-beta-hydroxysteroid dehydrogenase.
    Goldman AS
    J Clin Endocrinol Metab; 1968 Feb; 28(2):231-8. PubMed ID: 5688816
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the effect of ACTH and an inhibitor of 3-beta-hydroxysteroid dehydrogenase on the synthesis of adrenal microsomal proteins.
    Castells S; Bransome ED
    J Clin Endocrinol Metab; 1969 Apr; 29(4):539-49. PubMed ID: 4305280
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of 3 -hydroxysteroid dehydrogenase in the rat adrenal cortex. A metabolic and morphologic study.
    Finegold MJ; Basch RS
    Lab Invest; 1972 Jun; 26(6):767-77. PubMed ID: 4337976
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital effectiveness of an inhibitor of 3 beta-hydroxysteroid dehydrogenase administered before implantation of the rat blastula.
    Goldman AS
    Endocrinology; 1969 May; 84(5):1206-12. PubMed ID: 5777415
    [No Abstract]   [Full Text] [Related]  

  • 17. Defective testicular testosterone synthesis by the pseudohermaphrodite rat: an abnormality of 17 beta-hydroxysteroid dehydrogenase.
    Schneider G; Bardin CW
    Endocrinology; 1970 Nov; 87(5):864-73. PubMed ID: 4394887
    [No Abstract]   [Full Text] [Related]  

  • 18. 17 -hydroxysteroid dehydrogenase activity in human foetal adrenals, gonads and chorion from the first half of foetal life.
    Sulcová J; Capková A; Stárka L
    Endocrinol Exp; 1970; 4(2):83-93. PubMed ID: 5315305
    [No Abstract]   [Full Text] [Related]  

  • 19. 3 -Hydroxy- 5 -C 19 -and C 21 -steroid oxidoreductase activity in rat liver.
    Björkhem I; Einarsson K; Gustafsson JA
    Steroids; 1972 Apr; 19(4):471-6. PubMed ID: 4337647
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion of 11 ,17 ,21-trihydroxy-4-pregnene-3,20-dione-4- 14 c to 3 ,11 ,17 ,21-tetrahydroxy-5-pregnen-20-one- 14 C by reversal of the 3 -hydroxysteroid dehydrogenase-isomerase reactions.
    Shapiro MI
    Steroids; 1972 Dec; 20(6):669-80. PubMed ID: 4652474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.